We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
Website: https://members.lesusacanada.org/events/EventDetails.aspx?id=1824795&group=
Hosted by LES USA-Canada's DC Chapter, Maryland State Bar Association’s IP Section and the Bar Association of Montgomery County’s IP Section
Current bills before the House and Senate can dramatically effect the state of patenting in the United States. As with the American Invents Act (AIA), touted to be a panacea to all but a bane to innovation, these bills, although directed at curing problems in the patent process, are being lobbied by big tech and others to instead further curtail the rights of U.S. inventors, particularly the small or independent inventor.
The first bill is the Patent Eligibility Restoration Act (PERA), which seeks to provide better clarity over patent subject matter eligibility under Section 101 of the Patent Act.
The second bill is the Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act to reform practices of the Patent Trial and Appeal Board (PTAB) and promote fair treatment for inventors in these proceedings.
